Moleculin Biotech
MBRX
MBRX
6 hedge funds and large institutions have $213K invested in Moleculin Biotech in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$57K | |
| 2 | +$46K | |
| 3 | +$41K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$41K |
| 5 |
Citigroup
New York
|
+$5.67K |
Top Sellers
| 1 | -$122K | |
| 2 | -$66K | |
| 3 | -$9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 5 |
Morgan Stanley
New York
|
-$4K |